Samsung Biologics is a fully integrated contract service provider offering development, manufacturing, and testing services, all from a single location. We provide highly tailored solutions to clients, while meeting the evolving needs of the global healthcare industry.

With proven regulatory approvals and the largest single site capacity, Samsung Biologics is a trusted CDMO partner of choice, and is uniquely able to provide seamless offerings from cell line development to final fill/finish as well as laboratory testing services at every stage for biopharmaceutical products.

Our facilities are all cGMP compliant holding 364KL total capacity with scales ranging from 1KL and 5KL to 15KL. We continue to upgrade our capabilities to accommodate our clients by investing in single-use technology and additional aseptic filling capacity.

To maximize our operational efficiency and expand capabilities in response to growing biomanufacturing demands, Samsung Biologics is constructing a fourth plant, which will further advance the company’s standing as the world’s largest manufacturing facility at a single site—holding a 620KL total capacity upon completion.

We believe and are committed to an on-time, in-full delivery of the products we manufacture with our flexible manufacturing solutions, operational excellence, and proven expertise. 

Related Categories

Sales Markets

Western Europe; Eastern Europe; Asia; Oceania; North America (USA, Canada); Central America (e.g. Mexico); Central/South America; East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)